The President’s Commission on Combating Drug Addiction and the Opioid Crisis yesterday urged President Trump to declare the opioid epidemic a national emergency. “With approximately 142 Americans dying every day, America is enduring a death toll equal to September 11th every three weeks,” the commission said in a draft interim report to the president. “Your declaration would empower your cabinet to take bold steps and would force Congress to focus on funding and empowering the Executive Branch even further to deal with this loss of life.” The report also calls for federal action to eliminate barriers caused by the Medicaid Institutions for Mental Diseases exclusion, which the commission says will immediately open inpatient treatment to thousands of Americans; better align patient privacy laws specific to addiction with the Health Insurance Portability and Accountability Act; mandate prescriber education to enhance prevention; expand access to medication-assisted treatment and naloxone; combat illicit fentanyl; enhance data sharing among prescription drug monitoring programs; and enforce the Mental Health Parity and Addiction Equity Act. The commission expects to provide additional recommendations in its final report, due in the fall.

Related News Articles

Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.
Headline
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain.
Headline
The AHA and the National Quality Forum today released a guide to help hospitals and health systems working to deliver innovative, high-quality telebehavioral…
Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…